Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 16:12
Viracta Therapeutics Market Cap: 7.895M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.996M |
| November 01, 2024 | 7.663M |
| October 31, 2024 | 7.954M |
| October 30, 2024 | 8.080M |
| October 29, 2024 | 8.703M |
| October 28, 2024 | 9.164M |
| October 25, 2024 | 10.41M |
| October 24, 2024 | 9.567M |
| October 23, 2024 | 9.578M |
| October 22, 2024 | 9.314M |
| October 21, 2024 | 9.460M |
| October 18, 2024 | 9.058M |
| October 17, 2024 | 8.782M |
| October 16, 2024 | 8.822M |
| October 15, 2024 | 8.656M |
| October 14, 2024 | 8.869M |
| October 11, 2024 | 8.869M |
| October 10, 2024 | 8.869M |
| October 09, 2024 | 9.125M |
| October 08, 2024 | 9.271M |
| October 07, 2024 | 9.082M |
| October 04, 2024 | 9.184M |
| October 03, 2024 | 8.987M |
| October 02, 2024 | 9.145M |
| October 01, 2024 | 9.184M |
| Date | Value |
|---|---|
| September 30, 2024 | 9.121M |
| September 27, 2024 | 8.751M |
| September 26, 2024 | 8.692M |
| September 25, 2024 | 8.908M |
| September 24, 2024 | 8.869M |
| September 23, 2024 | 8.668M |
| September 20, 2024 | 8.822M |
| September 19, 2024 | 8.845M |
| September 18, 2024 | 8.652M |
| September 17, 2024 | 8.672M |
| September 16, 2024 | 9.066M |
| September 13, 2024 | 9.894M |
| September 12, 2024 | 9.551M |
| September 11, 2024 | 9.653M |
| September 10, 2024 | 9.125M |
| September 09, 2024 | 9.586M |
| September 06, 2024 | 9.500M |
| September 05, 2024 | 9.224M |
| September 04, 2024 | 9.192M |
| September 03, 2024 | 9.381M |
| August 30, 2024 | 8.420M |
| August 29, 2024 | 8.786M |
| August 28, 2024 | 8.841M |
| August 27, 2024 | 8.798M |
| August 26, 2024 | 10.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.663M
Minimum
Nov 01 2024
580.82M
Maximum
Feb 26 2021
125.70M
Average
76.31M
Median
Jan 18 2023
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.59B |
| Arbutus Biopharma Corp | 746.63M |
| GlycoMimetics Inc | 25.14M |
| FibroGen Inc | 30.52M |
| Cidara Therapeutics Inc | 94.52M |
Market Cap Related Metrics
| Price | 0.2003 |
| Earnings Yield | -579.1% |